These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 4344110)
1. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent. Nye ER; Jackson D; Hunter JD N Z Med J; 1972 Jul; 76(482):12-6. PubMed ID: 4344110 [No Abstract] [Full Text] [Related]
2. Response of hyperlipoproteinemia to colestipol. Sachs BA; Wolfman L N Y State J Med; 1973 May; 73(9):1068-70. PubMed ID: 4512165 [No Abstract] [Full Text] [Related]
3. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia. Miller NE; Clifton-Bligh P; Nestel PJ; Whyte HM Med J Aust; 1973 Jun; 1(25):1223-7. PubMed ID: 4579666 [No Abstract] [Full Text] [Related]
4. Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man. Miller NE; Clifton-Bligh P; Nestel PJ J Lab Clin Med; 1973 Dec; 82(6):876-90. PubMed ID: 4758739 [No Abstract] [Full Text] [Related]
5. Changes in plasma lipoprotein lipids in hypercholesterolaemic patients treated with the bile acid-sequestering resin, colestipol. Clifton-Bligh P; Miller NE; Nestel PJ Clin Sci Mol Med; 1974 Dec; 47(6):547-57. PubMed ID: 4375013 [No Abstract] [Full Text] [Related]
6. Colestipol therapy of hyperlipidemia in man. Sachs BA; Wolfman L Proc Soc Exp Biol Med; 1974 Dec; 147(3):694-7. PubMed ID: 4445156 [No Abstract] [Full Text] [Related]
7. Long-term cholesterol-lowering effect of colestipol resin in humans. Gross L; Figueredo R J Am Geriatr Soc; 1973 Dec; 21(12):552-6. PubMed ID: 4584170 [No Abstract] [Full Text] [Related]
8. Colestipol hydrochloride, a new hypolipidemic drug: a two-year study. Cooper EE; Michel AM South Med J; 1975 Mar; 68(3):303-9. PubMed ID: 1091001 [TBL] [Abstract][Full Text] [Related]
9. Diet and drug treatment of hyperlipidemia and atherosclerosis. Kuo PT Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101 [No Abstract] [Full Text] [Related]
13. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin. Glueck CJ; Fallat RW; Mellies M; Tsang RC Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057 [TBL] [Abstract][Full Text] [Related]
14. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia. Glueck CJ; Ford S; Scheel D; Steiner P JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098 [No Abstract] [Full Text] [Related]
15. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)]. Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910 [TBL] [Abstract][Full Text] [Related]
16. Ultracentrifugal demonstration of floating beta lipoproteins in type 3 hyperlipoproteinemia. Diagnostic value. Aubry F; Lapierre YL; Noël C; Davignon J Ann Intern Med; 1971 Aug; 75(2):231-7. PubMed ID: 5558651 [No Abstract] [Full Text] [Related]
17. The effects of colestipol resin and of colestipol plus clofibrate on the turnover of plasma cholesterol in man. Goodman DS; Noble RP; Dell RB J Clin Invest; 1973 Oct; 52(10):2646-55. PubMed ID: 4729058 [TBL] [Abstract][Full Text] [Related]
18. Familial hypobetalipoproteinemia: report of a case with psychomotor retardation. Brown BJ; Lewis LA; Mercer RD Pediatrics; 1974 Jul; 54(1):111-3. PubMed ID: 4365305 [No Abstract] [Full Text] [Related]
19. [Classification of hyperlipoproteinemias]. Zabel R Dermatol Monatsschr; 1974 Feb; 160(2):134-50. PubMed ID: 4369507 [No Abstract] [Full Text] [Related]
20. Results of colestipol therapy in Type II hyperlipoproteinemia. Lees AM; McCluskey MA; Lees RS Atherosclerosis; 1976; 24(1-2):129-40. PubMed ID: 182181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]